- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03516019
eFHS Messaging Trial
Messaging Intervention Trial in the Electronic Framingham Heart Study (eFHS)
In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device.
The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.
For the primary e-cohort, the investigators will build a custom mobile app for use within the Framingham Heart Study (FHS) to digitally collect data, compare it against research clinic-collected data, quantify risk factor burden, and perform CVD risk prediction. The app development will focus on 1) CVD risk factor data that would benefit from more frequent ascertainment than the every four to eight year FHS examination cycles; 2) circumstances where in vivo assessment may be superior to clinic-based assessment; 3) key endpoints of the FHS that are considered FHS landmarks. In addition to the eFHS App, participants will be offered wireless devices (Withings BP) to measure blood pressure and an Apple Watch to measure heart rate and steps per day.
For the messaging trial, the investigators will conduct a randomized factorial trial phase to test the effect of messaging strategies. Participants will be sent a weekly notification through the eFHS app. Participants will be randomly allocated to one of 8 groups defined according to the following: using personalized reminder messaging vs. standard neutral messaging; notification sent on a weekday vs. weekend; notification sent in the morning vs. the evening. The three main comparisons will be simultaneously evaluated according to a 2x2x2 factorial design.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02118
- Framingham Heart Study
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria for the eFHS study:
- Participants of the FHS Third Generation, Omni Group 2, and New Offspring Spouse Cohorts attending the in-person examination 3 with access to a smartphone or home internet access and English speaking/reading.
Specifically for the RCT substudy (re: engagement with select mobile health technologies):
- English-speaking individual
- Owns an iPhone with compatible iOS (version 9 or higher);
- Residence in the United States
- Provision of permissions for notifications and data sharing with the Research Center
- Provision of signed and dated informed consent
Exclusion Criteria:
- Participants who do not meet the inclusion criteria
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación factorial
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Weekday am personalized notices
Participants in this arm receive personalized weekday am notices on Wednesday at 7am.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent at 7 am.
notifications sent on Wednesday
|
Experimental: Weekday pm personalized notices
Participants in this arm receive a personalized weekday pm notices on Wednesday at 7pm.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent on Wednesday
notifications sent at 7 pm.
|
Experimental: Weekend am personalized notices
Participants in this arm receive a personalized weekend am notices on Saturday at 7am.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent at 7 am.
notifications sent on Saturday
|
Experimental: Weekend pm personalized notices
Participants in this arm receive personalized pm notices on Saturday at 7pm.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent at 7 pm.
notifications sent on Saturday
|
Experimental: Weekday am standard notices
Participants in this arm receive standard weekday notices on Wednesday at 7am.
|
notifications sent at 7 am.
notifications sent on Wednesday
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
Experimental: Weekday pm standard notices
Participants in this arm receive standard weekday notices on Wednesday at 7pm
|
notifications sent on Wednesday
notifications sent at 7 pm.
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
Experimental: Weekend am standard notices
Participants in this arm receive standard weekend notices on Saturday at 7am
|
notifications sent at 7 am.
notifications sent on Saturday
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
Experimental: Weekend pm standard notices
Participants in this arm receive standard weekend notices on Saturday at 7pm
|
notifications sent at 7 pm.
notifications sent on Saturday
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Adherence at 3 months to the weekly BP recording
Periodo de tiempo: 3 months
|
proportion of participants who submit their weekly blood pressure measurement at 3 months
|
3 months
|
Adherence at 3 months to the weekly HR recording
Periodo de tiempo: 3 months
|
proportion of participants who submit their weekly heart rate measurement at 3 months
|
3 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Adherence at one month to the weekly BP recording
Periodo de tiempo: 1 month
|
proportion of participants who submit their weekly blood pressure measurement at 1 month
|
1 month
|
Adherence at one month to the weekly HR recording
Periodo de tiempo: 1 month
|
proportion of participants who submit their weekly heart rate measurement at 1 month
|
1 month
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Adherence to survey response
Periodo de tiempo: 3 months
|
proportion of participants who complete the eFHS survey at 3 months
|
3 months
|
Adherence at 6 months to the weekly BP recording
Periodo de tiempo: 6 months
|
Comparison between the groups receiving personalized notices to the groups receiving standard notices
|
6 months
|
Adherence at 6 months to the weekly HR recording
Periodo de tiempo: 6 months
|
Comparison between the groups receiving personalized notices to the groups receiving standard notices
|
6 months
|
Adherence at 6 months to survey response
Periodo de tiempo: 6 months
|
Comparison between the groups receiving personalized notices to the groups receiving standard notices
|
6 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Joanne Murabito, MD ScM, Framingham Heart Study
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- H-36586
- 74624 (Otro número de subvención/financiamiento: Robert Wood Johnson Foundation)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Enfermedades cardiovasculares
-
Mayo ClinicInscripción por invitaciónRiesgo cardiovascular | Prevención cardiovascularEstados Unidos
-
University of DelawareReclutamientoFactor de riesgo cardiovascular | Salud cardiovascularEstados Unidos
-
Oregon Health and Science UniversityTerminadoEnfermedad cardiovascular | Factores de riesgo cardiovascularEstados Unidos
-
Medical College of WisconsinActivo, no reclutandoEnfermedades cardiovasculares | Factor de riesgo cardiovascular | Salud cardiovascularEstados Unidos
-
Hospital Mutua de TerrassaTerminadoEnfermedad cardiovascular | Factor de riesgo cardiovascularEspaña
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityTerminadoEnfermedad cardiovascular | Influencia psicosocial en la enfermedad cardiovascularEstados Unidos
-
Medical College of WisconsinTerminadoEnfermedades cardiovasculares | Factores de riesgo cardiovascular | Salud cardiovascular | Impacto del cantoEstados Unidos
-
Centre Hospitalier Universitaire DijonTerminadoPacientes de Alto Riesgo Cardiovascular | Pacientes de bajo riesgo cardiovascularFrancia
-
Shanghai 10th People's HospitalDesconocidoPresión arterial | Factor de riesgo cardiovascular | Mortalidad global | Mortalidad cardiovascular | Eventos cardiovasculares | Daño al órgano dianaPorcelana
-
Methodist Health SystemTerminado